Thrombelastography rotational (ROTEM®) utility for monitoring patients with haemophilia and factor VIII inhibitors treated with rFVIIa (NOVOSEVEN®)

被引：0
|
作者：
Garcia-Rodriguez, M. [1 ]
Alvarez, M. [1 ]
Martin-Salces, M. [1 ]
Fernandez, I [1 ]
Butta, N. [1 ]
Rivas, I [1 ]
Munoz, I [1 ]
Jimenez-Yuste, V [1 ]
Hernandez-Navarro, F. [1 ]
机构：
[1] Hosp La Paz, Hematol, Madrid, Spain
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-TH-604
引用
收藏
页码：1135 / 1135
页数：1
相关论文
共 50 条
  • [41] Zero incidence of factor VIII inhibitors and successful haemostatic response in previously factor VIII-treated patients with haemophilia A switching to turoctocog alfa in a noninterventional study
    Ettingshausen, Carmen Escuriola
    Katsarou, Olga
    Kotnik, Barbara Faganel
    Derlon, Annie Borel
    Schwarz, Rudolf
    Ypma, Paula F.
    Matytsina, Irina
    Dey, Sohan
    Schutgens, Roger E. G.
    HAEMOPHILIA, 2022, 28 (01) : 46 - 54
  • [42] Thrombin generation in haemophilia A patients with factor VIII inhibitors after infusion of recombinant factor VIIa
    Eichinger, S.
    Lubsczyk, B.
    Kollars, M.
    Traby, L.
    Zwiauer, K.
    Gleiss, A.
    Quehenberger, P.
    Kyrle, P. A.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (08) : 707 - 713
  • [43] Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors
    Kurth, M. A. H.
    Dimichele, D.
    Sexauer, C.
    Sanders, J. M.
    Torres, M.
    Zappa, S. C.
    Ragni, M.
    Leonard, N.
    HAEMOPHILIA, 2008, 14 (01) : 50 - 55
  • [44] Effective and safe use of recombinant factor VIIa (NovoSeven®) in elderly mild haemophilia A patients with high-titre antibodies against factor VIII
    Leebeek, FWG
    Kappers-Klunne, MC
    Jie, KSG
    HAEMOPHILIA, 2004, 10 (03) : 250 - 253
  • [45] Measurement of recombinant porcine factor VIII in patients with congenital haemophilia A and inhibitors in the presence of emicizumab
    Pfrepper, Christian
    Klamroth, Robert
    Ettingshausen, Carmen Escuriola
    Petros, Sirak
    Siegemund, Annelie
    Siegemund, Thomas
    HAEMOPHILIA, 2024, 30 (02) : 545 - 553
  • [46] Factor VIII and IX genotype characterisation of haemophilia patients with transient or permanent inhibitors in Argentina
    Rossetti, L.
    Szurkalo, I.
    Primiani, L.
    Neme, D.
    Candela, M.
    Bianco, R. Perez
    HAEMOPHILIA, 2010, 16 : 77 - 77
  • [47] The prevalence of factor VIII inhibitors and genetic aspects of inhibitor development in Chinese patients with haemophilia A
    Wang, X.
    Yang, R.
    Zhao, Y.
    Wu, J.
    Sun, J.
    Zhang, X.
    HAEMOPHILIA, 2010, 16 : 80 - 80
  • [48] The prevalence of factor VIII inhibitors and genetic aspects of inhibitor development in Chinese patients with haemophilia A
    Wang, X. F.
    Zhao, Y. Q.
    Yang, R. C.
    Wu, J. S.
    Sun, J.
    Zhang, X. S.
    Ding, Q. L.
    Ge, H. L.
    Wang, H. L.
    HAEMOPHILIA, 2010, 16 (04) : 632 - 639
  • [49] The in vitro procoagulant effect of recombinant porcine factor VIII in patients with inherited haemophilia A and inhibitors
    Dargaud, Yesim
    Nougier, Christophe
    Desage, Stephanie
    Meunier, Sandrine
    Lienhart, Anne
    HAEMOPHILIA, 2022, 28 : 40 - 41
  • [50] Domain specificity of factor VIII inhibitors during immune tolerance induction in patients with haemophilia A
    van Helden, P. M. W.
    Kaijen, P. H. P.
    Mauser-Bunschoten, E. P.
    Fischer, K.
    van den Berg, H. M.
    Voorberg, J.
    HAEMOPHILIA, 2010, 16 (06) : 892 - 901
12345